Immediate Impact
50 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Leutz Buon being referenced
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma
2021
Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Leutz Buon | 232 | 111 | 31 | 131 | 28 | 354 | |
| Massimiliano De Bortoli | 179 | 75 | 25 | 143 | 19 | 403 | |
| Vitina Grieco | 214 | 130 | 64 | 100 | 20 | 380 | |
| Brian L. Abbott | 145 | 102 | 52 | 201 | 24 | 397 | |
| Laura Quotti Tubi | 272 | 118 | 62 | 113 | 21 | 405 | |
| Katharina Lisenko | 103 | 127 | 48 | 76 | 24 | 305 | |
| Danielle Shafer | 168 | 118 | 81 | 148 | 30 | 388 | |
| Zhifu Xiang | 176 | 155 | 15 | 75 | 21 | 350 | |
| Ligen Liu | 160 | 132 | 40 | 84 | 28 | 349 | |
| Luigi Alfano | 267 | 43 | 26 | 92 | 23 | 380 | |
| Juan Li | 132 | 133 | 21 | 82 | 19 | 358 |
All Works
Loading papers...